カテゴリー： 世界, 医療/バイオ, Grand View Research

頭蓋内動脈瘤のグローバル市場2023-2030：外科的クリッピング、血管内コイリング

【英語タイトル】Intracranial Aneurysm Market Size, Share & Trends Analysis Report By Type (Surgical Clipping, Endovascular Coiling), By End-use (Hospitals, Clinics), By Region (Asia Pacific, North America, Europe), And Segment Forecasts, 2023 - 2030

Grand View Researchが出版した調査資料（GRV23NVB077）・商品コード：GRV23NVB077
・発行会社（調査会社）：Grand View Research
・発行日：2023年10月9日
・ページ数：110
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

頭蓋内動脈瘤市場の成長と動向
Grand View Research, Inc.の最新レポートによると、頭蓋内動脈瘤の世界市場規模は2023年から2030年にかけて年平均成長率9.08％を記録し、2030年には23億3000万米ドルに達すると予測されています。同市場の成長は、脳卒中症例の増加、脳血管障害を患う人々の発生率の増加、主要企業による継続的な製品の発売など、様々な要因によるものです。さらに、可処分所得水準が拡大し、医療へのアクセスが改善した発展途上国でも市場が急成長しています。現在、脳動脈瘤の原因は明確に解明されていません。しかし、加齢、脳外傷、遺伝性、高血圧、動脈硬化、感染症、座りっぱなしのライフスタイルなど、この症状にはさまざまな要因が関係しています。注目すべき症状は、脳神経の機能障害、局所的な頭痛、複視などです。

その結果、頭蓋内動脈瘤を患う人口の増加が市場の拡大に寄与しています。この分野の企業は、既存の治療法をより安全で効果的なものにする方法を常に模索しており、また新しい技術を導入することで、世界的に頭蓋内動脈瘤製品の需要が増加すると予想されています。例えば、2022年6月には、インド・メドトロニック社がCEマークを取得した第4世代のフローディフレクター「Pipeline Vantage with Shield Technology」が脳動脈瘤の血管内治療用に開発されました。新たに開発されたフローディフレクター「パイプラインバンテージ」は、シールドテクノロジーを搭載し、デリバリーシステムとインプラントの両方の設計の特徴を強化しています。標的血管の最内層で細胞の発達を促進する足場を開発することで、医師が脳動脈瘤や頭蓋内動脈瘤を送達、展開、修復することをより容易かつ確実にします。

頭蓋内動脈瘤市場レポートハイライト

- 2022年には、血管内コイリングセグメントが84.82%のシェアを占め、市場を支配しました。これは、低侵襲脳神経外科手術への応用が増加し、遠隔地にある複数の動脈瘤へのアクセスが容易であるためです。

- 2022年には、病院の最終用途セグメントが89.52%の最大売上シェアを占めました。頭蓋内動脈瘤手術は最も複雑な手術の一つであり、病院で利用可能な高品質で耐久性のある機器に依存しています。

- 2022年の市場シェアは北米が26.91％で圧倒的です。同市場は競争が激しく、既存企業も新興企業も製品の革新、合併、買収、提携を通じて業界シェアの獲得に努めています。

- そのため、北米における主要プレイヤーの存在が、同地域の市場成長を後押しすると予想されます。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. 頭蓋内動脈瘤の市場変数・傾向・範囲
第4章. 頭蓋内動脈瘤の世界市場：種類別予測・傾向分析
第5章. 頭蓋内動脈瘤の世界市場：最終用途別予測・傾向分析
第6章. 頭蓋内動脈瘤の世界市場：地域別予測・傾向分析
第7章. 競争状況

グローバル市場調査レポート販売サイトのwww.marketreport.jpです。

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Type
1.1.2. End-use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.3.5.1. Data for primary interviews in North America
1.3.5.2. Data for primary interviews in Europe
1.3.5.3. Data for primary interviews in Asia Pacific
1.3.5.4. Data for primary interviews in Latin America
1.3.5.5. Data for Primary interviews in MEA
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.6.2. Volume price analysis (Model 2)
1.6.2.1. Approach 2: Volume price analysis
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Type outlook
2.2.2. End-use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Intracranial Aneurysm Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Industry Value Chain Analysis
3.3.1. Reimbursement framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing incidence of neurological diseases
3.4.1.2. Technological advancements
3.4.1.3. Increasing preferance for targeted therapy approach
3.4.2. Market restraint analysis
3.4.2.1. Risk of DBS surgery
3.4.2.2. Complex regulatory framework
3.5. Intracranial Aneurysm Market Analysis Tools
3.5.1. Industry Analysis – Porter’s
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
3.5.2.1. Political landscape
3.5.2.2. Technological landscape
3.5.2.3. Economic landscape
3.5.3. Major Deals & Strategic Alliances Analysis
3.5.4. Market Entry Strategies
Chapter 4. Intracranial Aneurysm Market: Type Estimates & Trend Analysis
4.1. Definitions and Scope
4.1.1. Surgical Clipping
4.1.2. Endovascular Coiling
4.1.3. Flow Diverters
4.1.4. Others
4.2. Type Market Share, 2022 & 2030
4.3. Segment Dashboard
4.4. Global Intracranial Aneurysm Market by Type Outlook
4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5.1. Surgical Clipping
4.5.1.1. Surgical clipping market estimates and forecast 2018 to 2030 (USD Million)
4.5.2. Endovascular Coiling
4.5.2.1. Endovascular coiling market estimates and forecast 2018 to 2030 (USD Million)
4.5.3. Flow Diverters
4.5.3.1. Flow diverters market estimates and forecast 2018 to 2030 (USD Million)
4.5.4. Others
4.5.4.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Intracranial Aneurysm Market: End-use Estimates & Trend Analysis
5.1. Definitions and Scope
5.1.1. Hospitals
5.1.2. Clinics
5.1.3. Others
5.2. End-use Market Share, 2022 & 2030
5.3. Segment Dashboard
5.4. Intracranial Aneurysm Market by End-use Outlook
5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5.1. Hospitals
5.5.1.1. Hospitals market estimates and forecast 2018 to 2030 (USD Million)
5.5.2. Clinics
5.5.2.1. Clinics market estimates and forecast 2018 to 2030 (USD Million)
5.5.3. Others
5.5.3.1. Others market estimates and forecast 2018 to 2030 (USD Million)
Chapter 6. Intracranial Aneurysm Market: Regional Estimates & Trend Analysis
6.1. Regional market share analysis, 2022 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Regional Market Share and Leading Players, 2022
6.4.1. North America
6.4.2. Europe
6.4.3. Asia Pacific
6.4.4. Latin America
6.4.5. Middle East and Africa
6.5. Market Application, & Forecasts and Trend Analysis, 2018 to 2030:
6.6. North America
6.6.1. Market estimates and forecast, 2018 – 2030 (Revenue, USD Million)
6.6.2. U.S.
6.6.2.1. Key country dynamics
6.6.2.2. Competitive Scenario
6.6.2.3. Regulatory framework
6.6.2.4. Reimbursement scenario
6.6.2.5. U.S. market estimates and forecasts, 2018 – 2030
6.6.3. Canada
6.6.3.1. Key country dynamics
6.6.3.2. Competitive Scenario
6.6.3.3. Regulatory framework
6.6.3.4. Reimbursement scenario
6.6.3.5. Canada market estimates and forecasts, 2018 – 2030
6.7. Europe
6.7.1. UK
6.7.1.1. Key country dynamics
6.7.1.2. Competitive Scenario
6.7.1.3. Regulatory framework
6.7.1.4. Reimbursement scenario
6.7.1.5. UK market estimates and forecasts, 2018 – 2030
6.7.2. Germany
6.7.2.1. Key country dynamics
6.7.2.2. Competitive Scenario
6.7.2.3. Regulatory framework
6.7.2.4. Reimbursement scenario
6.7.2.5. Germany market estimates and forecasts, 2018 – 2030
6.7.3. France
6.7.3.1. Key country dynamics
6.7.3.2. Competitive Scenario
6.7.3.3. Regulatory framework
6.7.3.4. Reimbursement scenario
6.7.3.5. France market estimates and forecasts, 2018 – 2030
6.7.4. Italy
6.7.4.1. Key country dynamics
6.7.4.2. Competitive Scenario
6.7.4.3. Regulatory framework
6.7.4.4. Reimbursement scenario
6.7.4.5. Italy market estimates and forecasts, 2018 – 2030
6.7.5. Spain
6.7.5.1. Key country dynamics
6.7.5.2. Competitive Scenario
6.7.5.3. Regulatory framework
6.7.5.4. Reimbursement scenario
6.7.5.5. Spain market estimates and forecasts, 2018 – 2030
6.7.6. Denmark
6.7.6.1. Key country dynamics
6.7.6.2. Competitive Scenario
6.7.6.3. Regulatory framework
6.7.6.4. Reimbursement scenario
6.7.6.5. Denmark market estimates and forecasts, 2018 – 2030
6.7.7. Sweden
6.7.7.1. Key country dynamics
6.7.7.2. Competitive Scenario
6.7.7.3. Regulatory framework
6.7.7.4. Reimbursement scenario
6.7.7.5. Sweden market estimates and forecasts, 2018 – 2030
6.7.8. Norway
6.7.8.1. Key country dynamics
6.7.8.2. Competitive Scenario
6.7.8.3. Regulatory framework
6.7.8.4. Reimbursement scenario
6.7.8.5. Norway market estimates and forecasts, 2018 – 2030
6.8. Asia Pacific
6.8.1. Japan
6.8.1.1. Key country dynamics
6.8.1.2. Competitive Scenario
6.8.1.3. Regulatory framework
6.8.1.4. Reimbursement scenario
6.8.1.5. Japan market estimates and forecasts, 2018 – 2030
6.8.2. India
6.8.2.1. Key country dynamics
6.8.2.2. Competitive Scenario
6.8.2.3. Regulatory framework
6.8.2.4. Reimbursement scenario
6.8.2.5. India market estimates and forecasts, 2018 – 2030
6.8.3. China
6.8.3.1. Key country dynamics
6.8.3.2. Competitive Scenario
6.8.3.3. Regulatory framework
6.8.3.4. Reimbursement scenario
6.8.3.5. China market estimates and forecasts, 2018 – 2030
6.8.4. South Korea
6.8.4.1. Key country dynamics
6.8.4.2. Competitive Scenario
6.8.4.3. Regulatory framework
6.8.4.4. Reimbursement scenario
6.8.4.5. South Korea market estimates and forecasts, 2018 – 2030
6.8.5. Australia
6.8.5.1. Key country dynamics
6.8.5.2. Competitive Scenario
6.8.5.3. Regulatory framework
6.8.5.4. Reimbursement scenario
6.8.5.5. Australia market estimates and forecasts, 2018 – 2030
6.8.6. Thailand
6.8.6.1. Key country dynamics
6.8.6.2. Competitive Scenario
6.8.6.3. Regulatory framework
6.8.6.4. Reimbursement scenario
6.8.6.5. Thailand market estimates and forecasts, 2018 – 2030
6.9. Latin America
6.9.1. Brazil
6.9.1.1. Key country dynamics
6.9.1.2. Competitive Scenario
6.9.1.3. Regulatory framework
6.9.1.4. Reimbursement scenario
6.9.1.5. Brazil market estimates and forecasts, 2018 – 2030
6.9.2. Mexico
6.9.2.1. Key country dynamics
6.9.2.2. Competitive Scenario
6.9.2.3. Regulatory framework
6.9.2.4. Reimbursement scenario
6.9.2.5. Mexico market estimates and forecasts, 2018 – 2030
6.9.3. Argentina
6.9.3.1. Key country dynamics
6.9.3.2. Competitive Scenario
6.9.3.3. Regulatory framework
6.9.3.4. Reimbursement scenario
6.9.3.5. Argentina market estimates and forecasts, 2018 – 2030
6.10. MEA
6.10.1. South Africa
6.10.1.1. Key country dynamics
6.10.1.2. Competitive Scenario
6.10.1.3. Regulatory framework
6.10.1.4. Reimbursement scenario
6.10.1.5. South Africa market estimates and forecasts, 2018 – 2030
6.10.2. Saudi Arabia
6.10.2.1. Key country dynamics
6.10.2.2. Competitive Scenario
6.10.2.3. Regulatory framework
6.10.2.4. Reimbursement scenario
6.10.2.5. Saudi Arabia market estimates and forecasts, 2018 – 2030
6.10.3. UAE
6.10.3.1. Key country dynamics
6.10.3.2. Competitive Scenario
6.10.3.3. Regulatory framework
6.10.3.4. Reimbursement scenario
6.10.3.5. UAE market estimates and forecasts, 2018 – 2030
6.10.4. Kuwait
6.10.4.1. Key country dynamics
6.10.4.2. Competitive Scenario
6.10.4.3. Regulatory framework
6.10.4.4. Reimbursement scenario
6.10.4.5. Kuwait market estimates and forecasts, 2018 – 2030
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.2.1. Innovators
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2022
7.3.4. Medtronic
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Type benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Stryker
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Type benchmarking
7.3.5.4. Strategic initiatives
7.3.6. MicroPort Scientific Corporation.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Type benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Johnson & Johnson Services, Inc.
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Type benchmarking
7.3.7.4. Strategic initiatives
7.3.8. MicroVention Inc.
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Type benchmarking
7.3.8.4. Strategic initiatives
7.3.9. B. Braun Melsungen AG
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Type benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Integra LifeSciences
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Type benchmarking
7.3.10.4. Strategic initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global intracranial aneurysm market, by region 2018 - 2030 (USD Million)
Table 4 Global intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 5 Global intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 6 North America intracranial aneurysm market, by country, 2018 - 2030 (USD Million)
Table 7 North America intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 8 North America intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 9 U.S. intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 10 U.S. intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 11 Canada intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 12 Canada intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 13 Europe intracranial aneurysm market, by country, 2018 - 2030 (USD Million)
Table 14 Europe intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 15 Europe intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 16 UK intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 17 UK intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 18 Germany intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 19 Germany intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 20 France intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 21 France intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 22 Italy intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 23 Italy intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 24 Spain intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 25 Spain intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 26 Denmark intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 27 Denmark intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 28 Sweden intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 29 Sweden intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 30 Norway intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 31 Norway intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 32 Asia Pacific intracranial aneurysm market, by country, 2018 - 2030 (USD Million)
Table 33 Asia Pacific intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 34 Asia Pacific intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 35 Japan intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 36 Japan intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 37 China intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 38 China intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 39 India intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 40 India intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 41 Australia intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 42 Australia intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 43 Thailand intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 44 Thailand intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 45 South Korea intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 46 South Korea intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 47 Latin America intracranial aneurysm market, by country, 2018 - 2030 (USD Million)
Table 48 Latin America intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 49 Latin America intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 50 Brazil intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 51 Brazil intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 52 Mexico intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 53 Mexico intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 54 Argentina intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 55 Argentina intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 56 MEA intracranial aneurysm market, by country, 2018 - 2030 (USD Million)
Table 57 MEA intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 58 MEA intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 59 South Africa intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 60 South Africa intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 61 Saudi Arabia intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 62 Saudi Arabia intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 63 UAE intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 64 UAE intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)
Table 65 Kuwait intracranial aneurysm market, by type, 2018 - 2030 (USD Million)
Table 66 Kuwait intracranial aneurysm market, by end-use, 2018 - 2030 (USD Million)

★調査レポート[頭蓋内動脈瘤のグローバル市場2023-2030：外科的クリッピング、血管内コイリング] (コード：GRV23NVB077)販売に関する免責事項を必ずご確認ください。
★調査レポート[頭蓋内動脈瘤のグローバル市場2023-2030：外科的クリッピング、血管内コイリング]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の脳動脈瘤市場2021-2031：種類別（クリッピング術、血管内コイリング、フローダイバーター、その他）、エンドユーザー別
  • 世界のウェアラブルインジェクター市場2024-2030：種類別（オンボディ、オフボディ）、技術別（スプリングベース、モーター駆動）、エンドユーザー別（病院、クリニック）、用途別（腫瘍学）、地域別
  • ガイドワイヤの世界市場2023-2030：市場規模、シェア、動向分析
  • ガイドワイヤの世界市場2023-2030：市場規模、シェア、動向分析
  • 関節内補充療法の世界市場2023-2030：市場規模、シェア、動向分析
  • 関節内補充療法の世界市場2023-2030：市場規模、シェア、動向分析
  • 医療用繊維の世界市場2023-2030：市場規模、シェア、動向分析
  • 医療用繊維の世界市場2023-2030：市場規模、シェア、動向分析
  • 世界の水頭症シャント市場2024-2030：製品別（バルブ、カテーテル）、最終用途別（病院、外来手術センター）、地域別
  • 臨床検査機器のグローバル市場2023-2030：一般、分析、臨床、サポート、特殊

    • ◆H&Iグローバルリサーチのお客様（例）◆